Kratom

North Carolina Lawmakers Advance Bill Regulating Hemp-Derived Products And Other Substances
Kratom, CBD, Marijuana: Regulatory Update, Get Tuned In Under 2 Minutes
Rise Of Kava, Kratom And Plant-Based Products: Is This Company Shaping A New Wellness Trend?
Kratom, CBD, Marijuana: Regulatory Update, Get Tuned In Under 2 Minutes
Rise Of Kava, Kratom And Plant-Based Products: Is This Company Shaping A New Wellness Trend?
Psychedelics Reform In California, Wisconsin, Illinois, Massachusetts & Pennsylvania
Psyched: FDA Warning, DEA's Telehealth Extension, CA Gov's Veto, Congress On Kratom, M&As & More

Kratom Recent News

FDA's Scarce CBD Regulations, MO Weed Measures, Cannabis In NJ, Kratom's Legal Statues & More
Congressman Blames FDA For Damaging Public Trust Due To Lack Of CBD Regs
West Virginia Senators Discuss Making Kratom, Delta-8 & Delta-9 Schedule 1 Drugs, Schools' New Policy On Medical Marijuana & Naloxone
The Senate Judiciary Committee in West Virginia recently approved legislation that would place kratom, delta-8, and delta-10 products as Schedule 1 drugs.
Senators Booker, Lee & Pocan Behind Bill To Protect Psychoactive Herb Kratom
A bipartisan group of senators presented a bill to protect consumer access to kratom, a tropical plant native to Southeast Asia, which is currently not illegal and can produce effects similar to opioids, 
Novel Psychedelic Compound Shows Positive Results For Opioid Use Disorder Treatment
Kratom grows in several Asian countries and has been traditionally used by local communities as a natural home remedy for pain, depression and addiction.
Nirvana Life Sciences Researches Kratom-Derived Substance For Opioid Addiction
The Canadian-based psychedelics company Nirvana Life Sciences Inc. filed a patent for the deuterated form of 7-hydroxymitragynine (D7-h.), commonly known as Kratom. Nirvana focuses on developing mental health therapeutics including non-addictive chronic pain and relapse-preventing products.
Should The Psychoactive Herb Kratom Be Banned Globally? The FDA Seeks Public Comments
The Federal Drug Administration is seeking public comments on kratom, a tropical plant native to Southeast Asia, which is currently not illegal and can have “opioid-like” effects.